Stocks and Investing
Stocks and Investing
Wed, October 5, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, October 4, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Edward White Initiated (BOLT) at Strong Buy and Held Target at $8 on, Oct 4th, 2022
Edward White of HC Wainwright & Co., Initiated "Bolt Biotherapeutics, Inc." (BOLT) at Strong Buy and Held Target at $8 on, Oct 4th, 2022.
Edward has made no other calls on BOLT in the last 4 months.
There is 1 other peer that has a rating on BOLT. Out of the 1 peers that are also analyzing BOLT, all agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Daina Graybosch of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $4 on, Thursday, August 11th, 2022
Contributing Sources